Anti-influenza virus agent and screening method for anti-influenza virus agent
AssigneeJapan Science and Technology Agency
InventorsYoshihiro KAWAOKA, Tokiko WATANABE, Eiryo KAWAKAMI, Shinji WATANABE
Life of this patent
Estimating the term…
Loading patent…
AssigneeJapan Science and Technology Agency
InventorsYoshihiro KAWAOKA, Tokiko WATANABE, Eiryo KAWAKAMI, Shinji WATANABE
Estimating the term…
The present invention provides an anti-influenza virus agent that targets biomolecules of host cells including human cells and a method of screening a candidate molecule for the anti-influenza virus agent. That is, the present invention is an anti-influenza virus agent that has an effect of suppressing expression or a function of a gene that encodes a protein having an effect of suppressing incorporation of an influenza virus vRNA or an NP protein into influenza virus-like particles in host cells and the gene is at least one selected from the group including JAK1 gene and the like.
An anti-influenza virus agent that has an effect of suppressing expression of a gene that encodes a protein involved in incorporation of an influenza virus vRNA or an NP protein into influenza virus-like particles in host cells or an effect of suppressing a function of the protein,
An anti-influenza virus agent having an effect of suppressing expression of a gene that encodes a protein involved in influenza virus replication or transcription in host cells or an effect of suppressing a function of the protein,
An anti-influenza virus agent having an effect of suppressing expression of a gene that encodes a protein involved in formation of influenza virus-like particles in host cells or an effect of suppressing a function of the protein,
A screening method for an anti-influenza virus agent which is a method of screening a candidate compound for an anti-influenza virus agent,
Dependencies are inferred from the claim text.